Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 168

1.

Cardiovascular disease in chronic obstructive pulmonary disease.

Hunninghake DB.

Proc Am Thorac Soc. 2005;2(1):44-9. Review.

PMID:
16113468
2.

Effects of rosuvastatin, atorvastatin, simvastatin, and pravastatin on atherogenic dyslipidemia in patients with characteristics of the metabolic syndrome.

Deedwania PC, Hunninghake DB, Bays HE, Jones PH, Cain VA, Blasetto JW; STELLAR Study Group.

Am J Cardiol. 2005 Feb 1;95(3):360-6.

PMID:
15670545
3.

Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals. 2003.

Shepherd J, Hunninghake DB, Barter P, McKenney JM, Hutchinson HG.

Atheroscler Suppl. 2004 Oct;5(3):115-23. No abstract available.

PMID:
15531284
4.

Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.

Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW; Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group.

Clin Ther. 2004 Sep;26(9):1388-99. Erratum in: Clin Ther. 2005 Jan;27(1):142.

PMID:
15531001
5.
6.

Safety of rosuvastatin.

Shepherd J, Hunninghake DB, Stein EA, Kastelein JJ, Harris S, Pears J, Hutchinson HG.

Am J Cardiol. 2004 Oct 1;94(7):882-8.

PMID:
15464670
7.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program.

J Am Coll Cardiol. 2004 Aug 4;44(3):720-32. Review.

8.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program.

Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):e149-61. Review.

PMID:
15297292
9.

A summary of implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program.

Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):1329-30. No abstract available.

PMID:
15297284
10.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association.

Circulation. 2004 Jul 13;110(2):227-39. Review. Erratum in: Circulation. 2004 Aug 10;110(6):763.

PMID:
15249516
11.

Plasma homocysteine levels in living kidney donors before and after uninephrectomy.

Tsai MY, Aras O, Sozen H, Hanson NQ, Woll PS, Arends VL, Hunninghake DB, Matas AJ.

J Lab Clin Med. 2004 Jun;143(6):340-3.

PMID:
15192649
12.

Effects of lipid-altering treatment in diabetes mellitus and the metabolic syndrome.

Deedwania PC, Hunninghake DB, Bays H.

Am J Cardiol. 2004 Jun 3;93(11A):18C-26C. Review.

PMID:
15178513
13.

Rosuvastatin improves the atherogenic and atheroprotective lipid profiles in patients with hypertriglyceridemia.

Hunninghake DB, Stein EA, Bays HE, Rader DJ, Chitra RR, Simonson SG, Schneck DW.

Coron Artery Dis. 2004 Mar;15(2):115-23.

PMID:
15024300
14.

Comparison of health-related quality-of-life outcomes of men and women after coronary artery bypass surgery through 1 year: findings from the POST CABG Biobehavioral Study.

Lindquist R, Dupuis G, Terrin ML, Hoogwerf B, Czajkowski S, Herd JA, Barton FB, Tracy MF, Hunninghake DB, Treat-Jacobson D, Shumaker S, Zyzanski S, Goldenberg I, Knatterud GL; POST CABG Biobehavioral Study Investigators.

Am Heart J. 2003 Dec;146(6):1038-44.

PMID:
14660996
15.

Effect on high-density lipoprotein cholesterol of maximum dose simvastatin and atorvastatin in patients with hypercholesterolemia: results of the Comparative HDL Efficacy and Safety Study (CHESS).

Ballantyne CM, Blazing MA, Hunninghake DB, Davidson MH, Yuan Z, DeLucca P, Ramsey KE, Hustad CM, Palmisano J.

Am Heart J. 2003 Nov;146(5):862-9.

PMID:
14597936
16.

Differences in medical care and disease outcomes among black and white women with heart disease.

Jha AK, Varosy PD, Kanaya AM, Hunninghake DB, Hlatky MA, Waters DD, Furberg CD, Shlipak MG.

Circulation. 2003 Sep 2;108(9):1089-94. Epub 2003 Aug 25.

PMID:
12939228
17.

Comparative effects of simvastatin and atorvastatin in hypercholesterolemic patients with characteristics of metabolic syndrome.

Hunninghake DB, Ballantyne CM, Maccubbin DL, Shah AK, Gumbiner B, Mitchel YB.

Clin Ther. 2003 Jun;25(6):1670-86.

PMID:
12860491
18.

A dose-ranging study of a new, once-daily, dual-component drug product containing niacin extended-release and lovastatin.

Hunninghake DB, McGovern ME, Koren M, Brazg R, Murdock D, Weiss S, Pearson T.

Clin Cardiol. 2003 Mar;26(3):112-8.

19.

Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals.

Shepherd J, Hunninghake DB, Barter P, McKenney JM, Hutchinson HG.

Am J Cardiol. 2003 Mar 6;91(5A):11C-17C; discussion 17C-19C.

PMID:
12646338
20.

Angiographic changes in saphenous vein grafts are predictors of clinical outcomes.

Knatterud GL, White C, Geller NL, Campeau L, Forman SA, Domanski M, Forrester JS, Gobel FL, Herd JA, Hickey A, Hoogwerf BJ, Hunninghake DB, Terrin ML, Rosenberg Y.

Am Heart J. 2003 Feb;145(2):262-9.

PMID:
12595843
21.

A summary of the findings from the Post-CABG trial.

Hoogwerf BJ, Hunninghake DB, Knatterud G, Campeau L.

Minerva Cardioangiol. 2002 Aug;50(4):291-9. Review.

PMID:
12147960
22.

Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the post coronary artery bypass graft trial.

White CW, Gobel FL, Campeau L, Knatterud GL, Forman SA, Forrester JS, Geller NL, Herd JA, Hickey A, Hoogwerf BJ, Hunninghake DB, Rosenberg Y, Terrin ML; Post Coronary Artery Bypass Graft Trial Investigators.

Circulation. 2001 Nov 27;104(22):2660-5.

PMID:
11723015
23.

Roundtable discussion: therapeutic challenges and deficiencies.

Popma JJ, Hunninghake DB, Arad Y, Blumenthal RS, Boden WE, Selwyn AP.

Am J Cardiol. 2001 Oct 18;88(8A):42K-43K. No abstract available.

PMID:
11694219
24.
25.

Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement Study.

Simon JA, Hunninghake DB, Agarwal SK, Lin F, Cauley JA, Ireland CC, Pickar JH.

Ann Intern Med. 2001 Oct 2;135(7):493-501.

PMID:
11578152
26.

Peripheral arterial disease detection, awareness, and treatment in primary care.

Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR.

JAMA. 2001 Sep 19;286(11):1317-24.

PMID:
11560536
27.

The Minnesota Regional Peripheral Arterial Disease Screening Program: toward a definition of community standards of care.

Hirsch AT, Halverson SL, Treat-Jacobson D, Hotvedt PS, Lunzer MM, Krook S, Rajala S, Hunninghake DB.

Vasc Med. 2001;6(2):87-96.

PMID:
11530970
28.

A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.

Illingworth DR, Crouse JR 3rd, Hunninghake DB, Davidson MH, Escobar ID, Stalenhoef AF, Paragh G, Ma PT, Liu M, Melino MR, O'Grady L, Mercuri M, Mitchel YB; Simvastatin Atorvastatin HDL Study Group.

Curr Med Res Opin. 2001;17(1):43-50.

PMID:
11464446
29.
30.

The hemostatic effects of warfarin titration in post CABG patients in comparison to placebo treatment.

Walenga JM, Hoppensteadt D, Pifarré R, Fox NL, Forman S, Hunninghake DB, Campeau L, Herd JA, Hoogwerf BJ, Hickey A, Probstfield JL, Terrin ML.

J Thromb Thrombolysis. 2001 Apr;11(2):143-9.

PMID:
11406729
31.

Lipid-altering efficacy and safety of simvastatin 80 mg/day: worldwide long-term experience in patients with hypercholesterolemia.

Davidson MH, Stein EA, Hunninghake DB, Ose L, Dujovne CA, Insull W Jr, Bertolami M, Weiss SR, Kastelein JJ, Scott RS, Campodónico S, Escobar ID, Schrott HG, Bays H, Stepanavage ME, Wu M, Tate AC, Melino MR, Kush D, Mercuri M, Mitchel YB; Worldwide Expanded Dose Simvastatin Study Group.

Nutr Metab Cardiovasc Dis. 2000 Oct;10(5):253-62.

PMID:
11213534
32.

Introduction: missing the target with lipid-lowering therapy.

Hunninghake DB, McKenney JM.

Am J Manag Care. 2000 Nov;6(19 Suppl):S992-6. No abstract available.

33.

Roundtable discussion. Achieving more aggressive low-density lipoprotein cholesterol lowering.

Hunninghake DB, McKenney JM, Gotto AM Jr, Mehta JL, Jones PH.

Am J Manag Care. 2000 Nov;6(19 Suppl):S1008-16. No abstract available.

34.

Reduction of LDL cholesterol in patients with primary hypercholesterolemia by SCH 48461: results of a multicenter dose-ranging study.

Dujovne CA, Bays H, Davidson MH, Knopp R, Hunninghake DB, Stein EA, Goldberg AC, Jones P, Lipka LJ, Cuffie-Jackson C.

J Clin Pharmacol. 2001 Jan;41(1):70-8.

PMID:
11144997
35.

Lessons from the post coronary artery bypass graft study in evaluating and controlling technical variability in angiographic trials. Post CABG Investigators.

White CW, Campeau L, Canner P, Domanski M, Forrester JS, Gobel FL, Herd JA, Hoogwerf BJ, Hunninghake DB, Knatterud GL, LoPresti F; Post CABG Investigators.

Am J Cardiol. 2001 Jan 1;87(1):40-3.

PMID:
11137831
36.

Plasma cholesterol: an influencing factor in red blood cell oxygen release and cellular oxygen availability.

Buchwald H, Menchaca HJ, Michalek VN, Rohde TD, Hunninghake DB, O'Dea TJ.

J Am Coll Surg. 2000 Nov;191(5):490-7.

PMID:
11085728
37.

Effective and safe modification of multiple atherosclerotic risk factors in patients with peripheral arterial disease.

Garg R, Elam MB, Crouse JR 3rd, Davis KB, Kennedy JW, Egan D, Herd JA, Hunninghake DB, Johnson WC, Kostis JB, Sheps DS, Applegate WB.

Am Heart J. 2000 Nov;140(5):792-803.

PMID:
11054628
38.

Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators.

Pitt B, Byington RP, Furberg CD, Hunninghake DB, Mancini GB, Miller ME, Riley W.

Circulation. 2000 Sep 26;102(13):1503-10.

PMID:
11004140
39.
40.

Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels.

Kastelein JJ, Isaacsohn JL, Ose L, Hunninghake DB, Frohlich J, Davidson MH, Habib R, Dujovne CA, Crouse JR, Liu M, Melino MR, O'Grady L, Mercuri M, Mitchel YB.

Am J Cardiol. 2000 Jul 15;86(2):221-3. No abstract available. Erratum in: Am J Cardiol 2000 Oct 1;86(7):812.

PMID:
10913488
41.

Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators.

Knatterud GL, Rosenberg Y, Campeau L, Geller NL, Hunninghake DB, Forman SA, Forrester JS, Gobel FL, Herd JA, Hickey A, Hoogwerf BJ, Terrin ML, White C.

Circulation. 2000 Jul 11;102(2):157-65.

PMID:
10889125
42.

Incorporation of lean red meat into a National Cholesterol Education Program Step I diet: a long-term, randomized clinical trial in free-living persons with hypercholesterolemia.

Hunninghake DB, Maki KC, Kwiterovich PO Jr, Davidson MH, Dicklin MR, Kafonek SD.

J Am Coll Nutr. 2000 Jun;19(3):351-60.

PMID:
10872897
43.

Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group.

Ose L, Davidson MH, Stein EA, Kastelein JJ, Scott RS, Hunninghake DB, Campodonico S, Insull W, Escobar ID, Schrott HG, Stepanavage ME, Wu M, Tate AC, Melino MR, Mercuri M, Mitchel YB.

Clin Cardiol. 2000 Jan;23(1):39-46.

44.

Effects of lovastatin and warfarin on early carotid atherosclerosis: sex-specific analyses. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group.

Byington RP, Evans GW, Espeland MA, Applegate WB, Hunninghake DB, Probstfield J, Furberg CD.

Circulation. 1999 Jul 20;100(3):e14-7.

PMID:
10411862
45.

Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors. NHLBI post coronary artery bypass graft clinical trial. Post CABG Trial Investigators.

Campeau L, Hunninghake DB, Knatterud GL, White CW, Domanski M, Forman SA, Forrester JS, Geller NL, Gobel FL, Herd JA, Hoogwerf BJ, Rosenberg Y.

Circulation. 1999 Jun 29;99(25):3241-7.

PMID:
10385497
46.

Pharmacologic management of triglycerides.

Hunninghake DB.

Clin Cardiol. 1999 Jun;22(6 Suppl):II44-8. Review.

47.

Hemostatic effects of 1 mg daily warfarin on post CABG patients. Post CABG Studies Investigators.

Walenga JM, Hoppensteadt D, Pifarré R, Cressman MD, Hunninghake DB, Fox NL, Terrin ML, Probstfield JL.

J Thromb Thrombolysis. 1999 Jun;7(3):313-8.

PMID:
10373714
48.

Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial.

Hoogwerf BJ, Waness A, Cressman M, Canner J, Campeau L, Domanski M, Geller N, Herd A, Hickey A, Hunninghake DB, Knatterud GL, White C.

Diabetes. 1999 Jun;48(6):1289-94.

PMID:
10342818
49.

Rationale and design of the Arterial Disease Multiple Intervention Trial (ADMIT) pilot study.

Egan DA, Garg R, Wilt TJ, Pettinger MB, Davis KB, Crouse J, Herd JA, Hunninghake DB, Sheps DS, Kostis JB, Probstfield J, Waclawiw MA, Applegate W, Elam MB.

Am J Cardiol. 1999 Feb 15;83(4):569-75.

PMID:
10073863
50.

Supplemental Content

Loading ...
Support Center